122 related articles for article (PubMed ID: 33134179)
1. Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients.
Bignotti E; Zanotti L; Todeschini P; Zizioli V; Romani C; Capoferri D; Tognon G; Sartori E; Calza S; Odicino F; Ravaggi A
Front Oncol; 2020; 10():584022. PubMed ID: 33134179
[TBL] [Abstract][Full Text] [Related]
2. Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome.
Zanotti L; Bignotti E; Calza S; Bandiera E; Ruggeri G; Galli C; Tognon G; Ragnoli M; Romani C; Tassi RA; Caimi L; Odicino FE; Sartori E; Pecorelli S; Ravaggi A
Clin Chem Lab Med; 2012 Dec; 50(12):2189-98. PubMed ID: 23096757
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of HE4 as a prognostic biomarker in uterine cervical cancer
Dubey H; Ranjan A; Durai J; Khan MA; Lakshmy R; Khurana S; Gupta S; Meena J; Ray MD; Tanwar P; Chopra A; Tiwari S
Cancer Treat Res Commun; 2023; 34():100672. PubMed ID: 36525756
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients.
Bignotti E; Ragnoli M; Zanotti L; Calza S; Falchetti M; Lonardi S; Bergamelli S; Bandiera E; Tassi RA; Romani C; Todeschini P; Odicino FE; Facchetti F; Pecorelli S; Ravaggi A
Br J Cancer; 2011 Apr; 104(9):1418-25. PubMed ID: 21468050
[TBL] [Abstract][Full Text] [Related]
5. Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical Cancer.
Hwang WY; Suh DH; Kim K; Kim YB; No JH
Cancer Control; 2022; 29():10732748221097778. PubMed ID: 35506739
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer.
Paek J; Lee SH; Yim GW; Lee M; Kim YJ; Nam EJ; Kim SW; Kim YT
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):338-42. PubMed ID: 21683503
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patients.
Steffensen KD; Waldstrøm M; Brandslund I; Jakobsen A
Int J Gynecol Cancer; 2011 Aug; 21(6):1040-7. PubMed ID: 21738039
[TBL] [Abstract][Full Text] [Related]
8. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer.
Mo D; He F
Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019
[TBL] [Abstract][Full Text] [Related]
9. [Expression of serum human epididymis protein 4 in epithelial ovarian cancer and its correlation with prognosis].
Zheng H; Gao YN; Gao WJ; Gao M; Yan X
Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):445-9. PubMed ID: 24119905
[TBL] [Abstract][Full Text] [Related]
10. Expression level of serum human epididymis 4 and its prognostic significance in human non-small cell lung cancer.
Jiang Y; Wang C; Lv B; Ma G; Wang L
Int J Clin Exp Med; 2014; 7(12):5568-72. PubMed ID: 25664073
[TBL] [Abstract][Full Text] [Related]
11. Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.
Stiekema A; Lok C; Korse CM; van Driel WJ; van der Noort V; Kenter GG; Van de Vijver KK
Virchows Arch; 2017 Jun; 470(6):655-664. PubMed ID: 28401338
[TBL] [Abstract][Full Text] [Related]
12. HE4 is an independent prognostic marker in endometrial cancer patients.
Mutz-Dehbalaie I; Egle D; Fessler S; Hubalek M; Fiegl H; Marth C; Widschwendter A
Gynecol Oncol; 2012 Aug; 126(2):186-91. PubMed ID: 22525819
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of serum human epididymis protein 4 in patients with primary fallopian tube carcinoma.
Mi D; Zhang YX; Wang CJ; Feng Q; Qi P; Chen SQ
J Obstet Gynaecol Res; 2016 Oct; 42(10):1326-1335. PubMed ID: 27307153
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosis.
Liu W; Yang J; Chi PD; Zheng X; Dai SQ; Chen H; Xu BL; Liu WL
Int J Tuberc Lung Dis; 2013 Oct; 17(10):1346-53. PubMed ID: 24025389
[TBL] [Abstract][Full Text] [Related]
15. Clinical Usefulness of Human Epididymis Protein 4 in Lung Cancer.
Choi SI; Jang MA; Jeon BR; Shin HB; Lee YK; Lee YW
Ann Lab Med; 2017 Nov; 37(6):526-530. PubMed ID: 28840992
[TBL] [Abstract][Full Text] [Related]
16. A new marker for breast cancer diagnosis, human epididymis protein 4: A preliminary study.
Gündüz UR; Gunaldi M; Isiksacan N; Gündüz S; Okuturlar Y; Kocoglu H
Mol Clin Oncol; 2016 Aug; 5(2):355-360. PubMed ID: 27446579
[TBL] [Abstract][Full Text] [Related]
17. HE4 as a predictor of adjuvant chemotherapy resistance and survival in patients with epithelial ovarian cancer.
Aarenstrup Karlsen M; Høgdall C; Nedergaard L; Philipsen Prahm K; Schou Karlsen NM; Weng Ekmann-Gade A; Henrichsen Schnack T; Svenstrup Poulsen T; Jarle Christensen I; Høgdall E
APMIS; 2016 Dec; 124(12):1038-1045. PubMed ID: 27859687
[TBL] [Abstract][Full Text] [Related]
18. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
Zhang M; Zhao B; Xie J; Liang Y; Yang Z
Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
[TBL] [Abstract][Full Text] [Related]
19. Serum HE4 as a prognostic marker in endometrial cancer--a population based study.
Brennan DJ; Hackethal A; Metcalf AM; Coward J; Ferguson K; Oehler MK; Quinn MA; Janda M; Leung Y; Freemantle M; ; Webb PM; Spurdle AB; Obermair A
Gynecol Oncol; 2014 Jan; 132(1):159-65. PubMed ID: 24211402
[TBL] [Abstract][Full Text] [Related]
20. Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer.
Lamy PJ; Plassot C; Pujol JL
PLoS One; 2015; 10(6):e0128836. PubMed ID: 26030627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
